We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting (SBIRT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01300806
First Posted: February 23, 2011
Last Update Posted: May 22, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of California, San Francisco
February 17, 2010
February 23, 2011
May 22, 2013
July 2010
May 2013   (Final data collection date for primary outcome measure)
reduced substance use among HIV-positive people [ Time Frame: 6 months ]
reduced morbidity and mortality and substance use among HIV-positive people [ Time Frame: 6 months ]
Complete list of historical versions of study NCT01300806 on ClinicalTrials.gov Archive Site
technological innovation to improve the quality of medical care [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
The goal of this research is to assess the impact of the "screening, brief intervention, and referral to treatment" (SBIRT) intervention strategy for harmful substance use among HIV-positive people.

The specific aims of the study are:

  1. To assess the feasibility of conducting SBIRT using (1) a patient self-administered intervention embedded in a web-based Personal Health Record (PHR) compared to (2) a provider-administered SBIRT intervention guided by the Electronic Medical Record (EMR) during clinic appointments.
  2. To examine the acceptability of web-based PHRs to conduct and communicate SBIRT compared to EMR-activated SBIRT conducted by clinic staff, from the perspective of the patient and the provider.
  3. To assess the impact of SBIRT on risky drug and alcohol use in an HIV/AIDS population and subsequent effects on sexual risk behaviors and antiretroviral therapy (ART) adherence.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
primary care clinic patients
Substance Use
Not Provided
  • myHERO SBIRT
  • clinician administered SBIRT
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
210
May 2013
May 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age
  • confirmed prior HIV+ serostatus
  • ability to provide informed consent to be a participant over a 6 month period
  • English or Spanish speaking

Exclusion Criteria:

Inability to answer questions with interviewer assistance. Not receiving primary care in clinic.

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
 
NCT01300806
09035355
Yes
Not Provided
Not Provided
University of California, San Francisco
University of California, San Francisco
Not Provided
Principal Investigator: Carol Dawson Rose, PhD University of California, San Francisco
University of California, San Francisco
May 2013